With a market cap of under $200m Imu has been a falling knife...

With a market cap of under $200m Imu has been a falling knife since the end of 2021. I bought in 2nd half of 2023 and have a paper loss of over half my investment. Got plenty of IMUOEs. I will keep holding though my confidence is rattled. A couple of things brighten the picture. I have learnt a lot about cancer its treatment and prevention from holding this stock. I am actively trying to avoid health problems. I also believe the consequences of success arent always positive, nor are the consequences of failure necessarily negative. I think there must be some chance of recovery from here. They need a commercial deal, azercel being the most probable choice, this has to happen this year I reckon. A deal for the B cell or CF33 is another possibility. There might be a possibility the company will fold with very little value left to share holders but at this stage and at current share prices I think continuing holding is the way to go.

Its a hard game the market. I think what most went wrong for the company was they had a pipe line of drugs but failed to get a commercial deal for the most advanced, the B cell, Hervax or what ever it was. This left them to raise on market. The cash raisings and exuberance share valuations led to a collapse, the trend down continuing with recent market turmoil. I think I have no choice but to wait a bit more. Changed my sentiment from buy to hold.